• Return to Headlines

Incyte Corp Shares Down 23.3% Since SmarTrend's Sell Call (INCY)

By Shiri Gupta

SmarTrend identified a Downtrend for Incyte Corp (NASDAQ:INCY) on March 19th, 2018 at $87.42. In approximately 2 months, Incyte Corp has returned 23.34% as of today's recent price of $67.02.

Over the past year, Incyte Corp has traded in a range of $60.22 to $153.15 and is now at $67.02, 11% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 0.9%.

Incyte Corporation is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Incyte Corp.

Log in and add Incyte Corp (INCY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights incyte corp

Ticker(s): INCY